300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Liberia
Gibraltar
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Morocco
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Japan
Paraguay
Ireland
Canada
South Africa
United Kingdom
Georgia
France
Ghana
Iraq
Mali
Latvia
Denmark
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Philippines
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Angola
Europe
Cyprus
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Qatar
Bulgaria
Bahamas
Ecuador
Faroe Islands
Estonia
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Jersey
Bahrain
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lebanon
Lithuania
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Yaya Capital, VC Fund

Yaya Capital

VC Fund

Yaya Capital is a Venture capital and Private equity firm.

Total investments:
8
Last investment:
Lead investor:
0%

Last updated:

Industries Yaya Capital invests in

Health CareArtificial IntelligenceMachine LearningFitnessMedical

Stages Yaya Capital invests in

Series ASeries BVenture - Series Unknown

Countries Yaya Capital invests in

BrazilUnited States

Round sizes

Series A $8.8M–$52MSeries B $30M–$175M

Round size

Series A
$8.8M–$52M
Series B
$30M–$175M

Investment Focus

Industry

  • Health Care 5 (63%)
  • Artificial Intelligence 3 (38%)
  • Machine Learning 2 (25%)
  • Fitness 1 (13%)
  • Medical 1 (13%)
See all 9 industries →

Stage

  • Series A 4 (50%)
  • Series B 2 (25%)
  • Venture - Series Unknown 1 (13%)

Country

  • Brazil 3 (38%)
  • United States 3 (38%)

Investments

CompanyDescriptionRoundLinks
ISA Saúde ISA Saúde
ISA lab is to deliver the best solution for health and offers a humanized service. ISA is an online platform where one can select the process like examination, test, or vaccine. Then schedule and make payment online, receive ISA wherever one wants. Finally, they offer a facility to check the result online and rate their service. $30M / Series B / Oct 28, 2025
NeuralMed NeuralMed
NeuralMed is a native healthcare startup that analyzes all types of unstructured data from various sources to create a single safe and reliable data matrix. It develops solutions based on proprietary algorithms that maximize the full potential of real-time medical data. Its algorithms can organize patient flow by criticality and assist doctors inidentifying pathologies and structuring reports based on the analysis of free texts and images. Its solutions are dependable and easily integrated into any system, resulting in higher user adherence. Venture - Series Unknown / Nov 16, 2022
XP Health XP Health
XP Health is a health tech startup introducing a new kind of vision benefit for employees leveraging machine learning.Founded in 2019 by Antonio Moraes and James Wong, XP Health is an AI-powered vision benefits platform for employees and their families to get frames from the world’s leading designers like Tom Ford, Ray-Ban, Armani, Gucci, Coach.Its proprietary deep learning model uses facial recognition technology that recommends the best frames based on facial dimensions with 98% accuracy. The company is working with companies like Chegg, Zenefits, and Sequoia Consulting Group. $17.1M / Series A / Sep 28, 2022
ISA Saúde ISA Saúde
ISA lab is to deliver the best solution for health and offers a humanized service. ISA is an online platform where one can select the process like examination, test, or vaccine. Then schedule and make payment online, receive ISA wherever one wants. Finally, they offer a facility to check the result online and rate their service. $17M / Series A / Aug 09, 2022
Endpoint Health Endpoint Health
Endpoint Health is a precision immunology company that is breaking the efficacy barrier of traditional pharma's “one-size-fits-all” drug development strategy by developing precision therapies with outsized efficacy potential in autoimmune and inflammatory conditions. They’re accomplishing this by leveraging OMNAI, their proprietary AI-poweredpatient discovery platform, to identify and match high-potential therapies to the patients most likely to respond. $52M / Series A / Jun 02, 2022
Klivo Klivo
Klivo is a platform that connects multidisciplinary healthcare with the help of an application. $8.8M / Series A / Mar 07, 2022
Endpoint Health Endpoint Health
Endpoint Health is a precision immunology company that is breaking the efficacy barrier of traditional pharma's “one-size-fits-all” drug development strategy by developing precision therapies with outsized efficacy potential in autoimmune and inflammatory conditions. They’re accomplishing this by leveraging OMNAI, their proprietary AI-poweredpatient discovery platform, to identify and match high-potential therapies to the patients most likely to respond. Series A / Feb 09, 2022
Metagenomi Metagenomi
Metagenomi is using the power of metagenomics and machine learning to discover novel genome editing systems. $175M / Series B / Jan 25, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Cryptocurrency
Oil and Gas
Retail
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Theatre
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Liberia
Gibraltar
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Morocco
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Japan
Paraguay
Ireland
Canada
South Africa
United Kingdom
Georgia
France
Ghana
Iraq
Mali
Latvia
Denmark
Malaysia
Portugal
Sierra Leone
Rwanda
El Salvador
Philippines
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Bangladesh
Angola
Europe
Cyprus
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Qatar
Bulgaria
Bahamas
Ecuador
Faroe Islands
Estonia
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Jersey
Bahrain
Grenada
Israel
Iceland
Liechtenstein
Cambodia
Honduras
Lebanon
Lithuania
Mongolia
Slovenia
Peru
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Yaya Capital invest in?

Yaya Capital invests primarily in Health Care, Artificial Intelligence and Machine Learning startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in Brazil. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Yaya Capital's check size?

Yaya Capital typically joins rounds of $8.8M–$52M at Series A and $30M–$175M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Yaya Capital participates in.

When did Yaya Capital last invest?

The most recent investment recorded for Yaya Capital closed in Oct 2025. Shizune tracks 8 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Yaya Capital Yaya Capital Find emails